Futian Center for Chronic Disease Control

date:2025-10-17

Futian Center for Chronic Disease Control

I. Hospital Overview

Established in 2005, Shenzhen Futian District Chronic Disease Prevention and Treatment Hospital is a public, non-profit medical institution directly administered by the Futian District Government. It stands as Shenzhen's first tertiary-level specialized chronic disease hospital featuring “full-cycle chronic disease management.” Rooted in Futian and serving Shenzhen, the hospital focuses on core chronic disease areas, including hypertension, diabetes, early cancer screening, bone metabolism disorders, and mental health. It has established an integrated chronic disease prevention and control system encompassing “prevention-screening-diagnosis-treatment-rehabilitation-follow-up,” serving over 300,000 patient visits annually. It stands as one of the benchmark institutions for chronic disease prevention and control in the Guangdong-Hong Kong-Macao Greater Bay Area.

II. Technical Advantages

Futian Center for Chronic Disease Control pursues “precision, intelligence, and integration” as its technological development direction, forming three core strengths:

1. Multidisciplinary Team (MDT) Model: For complex cases such as hypertension with cardiovascular/cerebrovascular risks or diabetes with nephropathy, it integrates specialists from endocrinology, cardiology, nephrology, nutrition, and other disciplines to provide personalized treatment plans.

2. Smart Healthcare Empowerment: Established an “Internet+Chronic Disease Management” platform. Real-time patient monitoring via wearable devices (e.g., continuous glucose monitors, smart blood pressure monitors) combined with AI algorithms for early warning of condition changes enables seamless data exchange between home and hospital settings.

3. Early Prevention and Treatment Focus:

• Cancer Early Screening Center: Offers low-dose spiral CT for lung cancer and fecal DNA testing for colorectal cancer, advancing tumor detection by 3-5 years.

• Osteoporosis Center: Combines dual-energy X-ray absorptiometry (DXA) with bone metabolism marker testing for precise fracture risk assessment.

III. Hospital Specialty Strengths

Futian Center for Chronic Disease Control focuses on specialty development, establishing five regionally leading departments:

• Hypertension Center: A partner institution of the National Cardiovascular Center, offering secondary hypertension screening and precision medication guidance for resistant hypertension, achieving an 82% standardized control rate among managed patients.

• Diabetes Prevention and Treatment Center: Designated as Shenzhen's training base for diabetic foot prevention, it pioneers combined therapy using “insulin pumps + continuous glucose monitoring,” reducing diabetic foot amputation rates to 1.2% (below the national average).

• Cancer Early Screening and Health Management Department: Futian District's sole public-designated cancer screening facility, conducting over 50,000 screenings annually and achieving a 65% early diagnosis rate for lung and colorectal cancers.

• Psychiatry and Psychology Department: Focuses on comorbid depression/anxiety in chronic disease patients. Offers “Mind-Body Co-Treatment” clinics combining Cognitive Behavioral Therapy (CBT) with repetitive Transcranial Magnetic Stimulation (rTMS), achieving over 70% improvement in patient psychological status.

• Bone Metabolism Disease Center: Provides personalized osteoporosis treatment and exercise rehabilitation guidance for conditions like senile osteoporosis and parathyroid dysfunction, reducing fragility fracture incidence.

IV. Hospital Department Structure

Department layout aligns with chronic disease prevention and treatment needs, including:

• Clinical Departments: Internal Medicine (including hypertension and diabetes subspecialties), Cancer Screening, Bone Metabolic Diseases, Psychiatry & Psychology, Rehabilitation Medicine, Family Medicine;

• Preventive Health Departments: Chronic Disease Prevention & Control, Health Management Center, Vaccination Clinic;

• Support Departments: Medical Laboratory Center (including genetic testing), Medical Imaging Center (DR, CT, Ultrasound), Functional Testing Department (Holter ECG/BP monitoring);

• Specialized Platforms: Internet Hospital, Chronic Disease Big Data Center, Patient Follow-up Center.

V. Medical Equipment and Devices

Futian Center for Chronic Disease Control is equipped with internationally advanced chronic disease diagnostic and treatment devices, including:

• Imaging: Siemens 16-slice spiral CT, Digital X-ray Bone Densitometer (DXA), Mammography Unit;

• Diagnostics: Fully Automated Biochemical Analyzer (Roche Cobas 8000), Chemiluminescence Immunoassay Analyzer (Abbott i2000), Liquid Biopsy Cancer Early Screening System;

• Smart Management: Continuous glucose monitoring system (Medtronic), smart blood pressure wristband (customized in collaboration with Huawei), telemedicine platform terminals;

• Rehabilitation: Intelligent gait analysis system, osteoporosis treatment device (electromagnetic field stimulation), upper/lower limb rehabilitation robots.

VI. Hospital Nature and Grade

• Nature: Public non-profit medical institution under the Futian District Health Bureau;

• Grade: Grade III Chronic Disease Specialist Hospital (accredited in 2022), among Shenzhen's first district-level chronic disease prevention institutions to achieve this designation.

VII. International Patient Services

Actively responding to the internationalization strategy of “Healthy China,” Futian Center for Chronic Disease Control offers a suite of international patient services:

• Multilingual Support: Dedicated English, Cantonese, and Japanese-speaking patient guides and translators; bilingual versions of medical records and test reports provided;

• Streamlined Access: Dedicated international patient zones simplify registration, payment, and testing procedures; support direct billing with international health insurance (e.g., Hong Kong Hospital Authority, Singapore Medisave).

• Culturally Adaptive Services: Respects diverse cultural practices with personalized arrangements including halal meals and religious prayer rooms.

• Remote Consultations: Collaborations with Johns Hopkins Hospital (USA) and King's College Hospital Chronic Disease Center (UK) enable scheduled international expert telemedicine consultations.

VIII. Medical Rankings & Patient Feedback

• Domestic Rankings:

• Ranked among China's Top 100 Hospitals for Chronic Disease Management for three consecutive years (Top 5 in South China);

• Ranked 2nd in Shenzhen's Chronic Disease Management Quality Evaluation for Grade II+ Hospitals;

• International Recognition: Recommended as a best practice case for “Innovative Chronic Disease Management Models” by the World Health Organization (WHO) in 2023;

• Patient Feedback: The 2023 International Patient Satisfaction Survey revealed that 92% of patients acknowledged “professional medical expertise,” while 89% affirmed “humanized service,” with firm reputations in areas like diabetic foot care and early cancer screening.

IX. Contact Information and Transportation Routes

• Address: No. 109, Fuhua 3rd Road, Futian District, Shenzhen (near Futian CBD, adjacent to Shenzhen Convention and Exhibition Center);

• Transportation Routes:

• Subway: Exit B of “Convention and Exhibition Center Station” (Lines 1/4), 5-minute walk;

• Bus: “Futian District Chronic Disease Prevention Hospital” (M474, M500) or “Convention Center” (Routes 3, 15, 33, etc.);

• Driving: Hospital underground parking (30 spaces, first 2 hours free); multiple public parking lots available on nearby Fuhua 3rd Road and Jintian Road.

Futian Center for Chronic Disease Control, with its mission to “make chronic diseases preventable and controllable,” is continuously deepening collaborations with leading domestic and international institutions. It is committed to becoming a “technological hub” and “humanistic haven” for chronic disease prevention and control in the Guangdong-Hong Kong-Macao Greater Bay Area, providing more compassionate medical services to chronic disease patients worldwide.

Document dated 2025-10-17 22:23 Modify